Hi,
Is your research aiming to produce results that could lead to a new medical device, medicine, food stuff or diagnostic test? Do you know what should be taken account already at research phase or during and after Business Finland´s Research to Business (R2B, previously TUTLI) project? What kind of documentation should you make from your experiments?
University Innovation Centre is arranging a training from regulatory requirements. The focus is what we should do already during research phase in order to speed up the regulatory requirements.
When: part 1/2: 8th Dec 2020 at 12.00 - 16.00 part 2/2: 9th Dec 2020 at 12.00 - 16.00
Where: Online training, Participation link: https://oulu.zoom.us/j/64461152348
To whom: Researchers whose research relates to themes that can produce in the future new medical devices (including software), medicines, food stuffs or diagnostic tests.
Registrationhttps://link.webropolsurveys.com/S/4D203C29C10AD189 before 1st Dec 2020
More info: Maarit.Jokela@oulu.fimailto:Maarit.Jokela@oulu.fi or from Patiohttps://patio.oulu.fi/fi/tapahtumat/regulatory-and-financial-planning-life-science-health-tech-research-projects
Organized by: University Innovation Centre Implemented by: Kasve Ltd
Welcome!
Best wishes,
Maarit
P.S. Please forward this message to your colleagues who could be interested in this topic!
Maarit Jokela, PhD (Biochem.) Innovation Manager University of Oulu University Innovation Centre P.O.Box 4300 (street address: Erkki Koiso-Kanttilan katu 1) FI-90014 University of Oulu FINLAND
tel. +358-40-355 9660 Internal mail: 8 INNO Room: YT105 / Linnanmaa campus
https://fi.linkedin.com/in/maaritjokela
[cid:image002.jpg@01D6AD18.AFB58EA0] Follow us on Facebookhttps://www.facebook.com/unioulu/, Instagramhttps://www.instagram.com/unioulu/?hl=fi, Linkedinhttps://www.linkedin.com/school/university-of-oulu/ and Twitterhttps://twitter.com/unioulu. The content of this message is confidential. If you are not a recipient indicated or intended in this message or you think this message may have been addressed to you in error, please inform us by an email reply and then delete the message. In such case it is forbidden to copy, forward, or in any way reveal the contents of this message to anyone
